Summit X, LLC Soligenix, Inc. Transaction History

Summit X, LLC

  • $438 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 29, 2021
SELL
$1.26 - $2.75 $17,640 - $38,500
-14,000 Closed
0 $0
Q2 2020

Aug 13, 2020
BUY
$1.36 - $2.26 $3,400 - $5,649
2,500 Added 21.74%
14,000 $30,000
Q1 2020

May 13, 2020
SELL
$1.42 - $3.34 $1,420 - $3,340
-1,000 Reduced 8.0%
11,500 $19,000
Q4 2019

Jan 23, 2020
BUY
$0.87 - $1.45 $10,875 - $18,125
12,500 New
12,500 $18,000

Others Institutions Holding SNGX

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About SOLIGENIX, INC.

SNGX Quotes by TradingView
  • Ticker SNGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,105,200
  • Market Cap $171M
  • Description
  • Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has c...
More about SNGX
Track This Portfolio

Track Summit X, LLC Portfolio

Follow Summit X, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit X, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit X, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email